PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.
about
HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoterThe human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcriptionInteraction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasomeCDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNARelief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoterDomains in the SPT5 protein that modulate its transcriptional regulatory propertiesTranscriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent mannerCoordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcriptionThe HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factorThe expanding role of Tax in transcriptionThe site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivationP-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase IIRegulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop.Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinasesMechanism and regulation of transcriptional elongation by RNA polymerase II.Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell linesA block to human immunodeficiency virus type 1 assembly in murine cells.Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells.Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly.Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines.TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication.A nucleolar TAR decoy inhibitor of HIV-1 replication.Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiationThe interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 proteinNegative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoproteinMD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding.Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replicationRecruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressorInhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant.Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.Chromatin dynamics associated with HIV-1 Tat-activated transcription.Lost in transcription: molecular mechanisms that control HIV latencyEffects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells.Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA.Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism
P2860
Q22007982-2B69579C-E385-4CCF-B09F-EA114E1DE8FFQ24318776-6522BA9D-04F1-4E09-834B-1B0E82F89827Q24548261-1BEF002C-2D00-4117-8561-6534C4406566Q24550765-96F1B00B-5596-425F-B570-4A76CCEE4B76Q24552532-BDEF4CAC-4181-45DD-B0E9-BDE2C7601570Q24554258-8E8DC10A-5AB1-40E2-9150-DDE4141F56FFQ24554483-AB1C3871-CE56-421C-83B2-0FB712629AB9Q24559797-B0C56B9F-C9BB-46D4-BB4F-A6C6C475E6D6Q24596637-9BCED201-79BD-4AF6-A870-5E64FC4983DFQ24797204-98EEE44F-F0FB-470F-9F73-E3D1DC7FB7BAQ28361880-0257FD83-0B98-4551-8B1C-F5AFC35A6060Q29620167-6B3840D2-22FF-4DB3-89EA-D56B28D953E7Q30350982-D2F29323-16F1-4BD4-B8E8-CFD4DAAA063CQ33196801-6066E105-E954-42D2-A16F-5B7E66CBD6D3Q33373237-9D950816-BBBA-419A-AF1C-4576E89BBAEDQ33653316-AF718018-7C4D-4133-85BF-5652FAEE9920Q33680820-BD1363E2-D405-448F-8459-DC184FE51B19Q33786066-66DED528-5CA5-45B6-ACF8-5D8B7E4E0A1BQ33802821-98158FA7-C91E-4103-8B8C-EC7BD8679226Q33836069-419ADB99-1519-413F-B65C-39374899ABBBQ33837992-E7DC6423-DE3A-4BB4-92A6-A8741D4F62B0Q33849629-BB111B0B-C1B9-44FF-AEDD-FDC611A1E8C7Q34030432-376779F1-9CFF-4A7D-8991-1F96C47DB47DQ34391750-559044C2-CF6B-4253-BB78-3A61530A0B51Q34467420-79538E6C-88CF-4E39-BDA9-E02F523081E5Q35040154-9B1CE957-9F78-4A19-B537-B5DA088A31ACQ35072999-5C08EC51-3B78-48C5-8DFB-7E7F7F357315Q35211232-6C33FAF2-58BE-4C6D-B77C-ECA09403FEB3Q35990647-3E7C7FDE-98CA-4D59-B87F-ED149120FC28Q36274198-35E35A2F-DD24-4633-8C69-839051ADE094Q36390969-61E9A776-D485-4EF7-899C-BF9556A021E4Q36405698-B46469E6-B088-4376-945C-7335C235F2B8Q36423989-29DB5730-733B-4C0E-9817-1183CB7A3673Q36850296-DC1E3E0C-2EA3-4CCD-AEE6-B0D66CE84C48Q37191856-6CBA1495-932D-4550-A621-9002E952737EQ37589012-1EA1AF5B-0581-4998-B9E2-1B88D28384BCQ38091888-A27C273D-52FF-486A-9F83-B12FEA89B6F5Q38557763-13AE13C4-30F9-4F87-A7AF-456656928A24Q39272683-0BA99A11-3C59-48D6-B656-0D8F9514E614Q39446082-6E89CFB1-E21C-45CD-9964-31077A664372
P2860
PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
PITALRE, the catalytic subunit ...... us Tat transactivation in vivo
@nl
PITALRE, the catalytic subunit ...... s Tat transactivation in vivo.
@ast
PITALRE, the catalytic subunit ...... s Tat transactivation in vivo.
@en
PITALRE, the catalytic subunit ...... s Tat transactivation in vivo.
@en-gb
type
label
PITALRE, the catalytic subunit ...... us Tat transactivation in vivo
@nl
PITALRE, the catalytic subunit ...... s Tat transactivation in vivo.
@ast
PITALRE, the catalytic subunit ...... s Tat transactivation in vivo.
@en
PITALRE, the catalytic subunit ...... s Tat transactivation in vivo.
@en-gb
prefLabel
PITALRE, the catalytic subunit ...... us Tat transactivation in vivo
@nl
PITALRE, the catalytic subunit ...... s Tat transactivation in vivo.
@ast
PITALRE, the catalytic subunit ...... s Tat transactivation in vivo.
@en
PITALRE, the catalytic subunit ...... s Tat transactivation in vivo.
@en-gb
P2093
P2860
P1433
P1476
PITALRE, the catalytic subunit ...... s Tat transactivation in vivo.
@en
P2093
P2860
P304
P407
P577
1998-05-01T00:00:00Z